Massimo Breccia, Elisabetta Abruzzese, Alessandra Iurlo, Antonella Gozzini, Alessandro Isidori, Domenica Gangemi, Patrizia Pregno and Giuliana Alimena (2016) “Efficacy and safety of second-line ponatinib after failure of a single previous tyrosine kinase inhibitor for chronic myeloid leukemia patients in chronic phase”, Haematologica. Pavia, Italy, 101(6), pp. e267-e268. doi: 10.3324/haematol.2016.145623.